🔎 Trials Near Me

Beranda › Kanker Paru › South Carolina › Charleston

Uji klinis Kanker Paru di Charleston, SC

11 studi untuk Kanker Paru mencari peserta di lokasi sekitar Charleston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Menerima pesertaFase 3
  • Ralph H Johnson VA Medical Center, Charleston
  • Medical University of South Carolina, Charleston
Usia 70 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • Bon Secours Saint Francis Hospital, Charleston
  • Medical University of South Carolina, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04267848

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Menerima pesertaFase 3
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06312137

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • Medical University of South Carolina, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

Health Education Approach to Lung Screening

Menerima pesertaSukarelawan sehat diterima
  • Medical University of South Carolina, Charleston
Usia 50 hingga 80 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06070870

Prediction Augmented Screening Initiative

Menerima peserta
  • Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Usia 50 hingga 80 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT06538636

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Ralph H Johnson VA Medical Center, Charleston
  • Medical University of South Carolina, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2/3
  • Medical University of South Carolina, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06616584

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Medical University of South Carolina, Charleston
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Menerima pesertaStudi observasional
  • Medical University of South Carolina (MUSC), Charleston
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Menerima pesertaStudi observasional
  • Ralph H. Johnson VA Health Care System, Charleston
Usia 29 hingga 85 · Semua jenis kelamin · Diperbarui 13 Nov 2024 · NCT06426628

Uji klinis Kanker Paru di kota lain

Studi lain di Charleston

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.